Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025
Compare Profit and Loss Results of Anlon Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
176.00
287.00
-111.00
-38.68%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
176.00
287.00
-111.00
-38.68%
Expenditure (Ex Depriciation)
Stock Adjustments
-16.00
0.00
-16.00
0%
Raw Materials Consumed
129.00
105.00
24.00
22.86%
Power & Fuel Cost
3.00
0.00
3.00
0%
Employee Cost
5.00
70.00
-65.00
-92.86%
Operating Expenses
3.00
0.00
3.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
28.00
-28.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
1.00
1.00
100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
229.00
-99.00
-43.23%
Operating Profit (PBDIT) excl Other Income
46.00
58.00
-12.00
-20.69%
Other Income
0.00
11.00
-11.00
-100.00%
Operating Profit (PBDIT)
46.00
70.00
-24.00
-34.29%
Interest
4.00
1.00
3.00
300.00%
Profit before Depriciation and Tax
42.00
69.00
-27.00
-39.13%
Depreciation
1.00
9.00
-8.00
-88.89%
Profit Before Taxation & Exceptional Items
40.00
59.00
-19.00
-32.20%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
40.00
57.00
-17.00
-29.82%
Provision for Tax
12.00
14.00
-2.00
-14.29%
Profit After Tax
27.00
43.00
-16.00
-37.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
148.00
-125.00
-84.46%
Profit Available for appropriations
50.00
191.00
-141.00
-73.82%
Appropriations
50.00
191.00
-141.00
-73.82%
Equity Dividend (%)
0%
200%
-200.00
Earnings Per Share
5.84
6.4
-0.56
-8.75%
Profit And Loss - Net Sales
Net Sales 176.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025
Profit And Loss - Interest
Interest 4.35 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 27.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025